Johanna Joyce, Professor at the University of Lausanne and Full Member of the international Ludwig Institute for Cancer Research, shared a post on LinkedIn:
“European cancer research requires renewed urgency
I’m delighted to join René Bernards, Anton Berns, and Michael Baumann in a new Nature Cancer Commentary calling for renewed urgency in how Europe supports cancer research, prevention, and innovation.
Every year, 1.5 million people in Europe die from cancer. And while Europe has extraordinary scientific talent and our science is world-class, the path from discovery to patient impact is still far too fragmented.
Basic research – the engine of innovation – continues to face increasing pressure, while translation, clinical research, prevention, and biotech development remain unevenly supported across Europe.
In this article, we outline seven strategic priorities to strengthen Europe’s leadership – from sustained investment in curiosity-driven basic research, to stronger academic translation, to better support for early-career scientists and innovators, and to truly integrating patients as partners in research and clinical decision making – that could transform Europe’s research ecosystem and accelerate progress for patients across the full cancer continuum.
Europe has the talent and the infrastructure, and the solutions are within reach. What we need now is long-term vision, political will, and a commitment to ensuring that scientific discoveries lead to faster, fairer, and more effective outcomes for patients who need them most.”
Title: European cancer research requires renewed urgency
Authors: René Bernards, Anton Berns, Johanna A. Joyce, Michael Baumann
More posts featuring Johanna Joyce on OncoDaily.